Title:
新型コロナウイルス感染症（ＣＯＶＩＤ－１９）の治療及び／又は予防剤
Document Type and Number:
Japanese Patent JP7058026
Kind Code:
B2
Abstract:
The present invention provides a therapeutic and/or preventive agent for coronavirus disease 2019 (COVID-19) comprising 5-aminolevulinic acid (ALA) or its derivative or a salt thereof and provides a method for treating and/or preventing coronavirus disease 2019 (COVID-19) using the therapeutic and/or preventive agent.
Inventors:
Kiyoshi Kita
Koichi Morita
Jiro Yasuda
Yasuaki Sakurai
Satoshi Kawada
Toru Tanaka
Motoyasu Tomioka
Kiyoshi Fujine
Koichi Morita
Jiro Yasuda
Yasuaki Sakurai
Satoshi Kawada
Toru Tanaka
Motoyasu Tomioka
Kiyoshi Fujine
Application Number:
JP2021072865A
Publication Date:
April 21, 2022
Filing Date:
April 22, 2021
Export Citation:
Assignee:
Neopharma Japan Co., Ltd.
National University Corporation Nagasaki University
National University Corporation Nagasaki University
International Classes:
A61K31/197; A61K31/28; A61K31/295; A61K31/30; A61K31/315; A61K33/24; A61K33/26; A61K33/30; A61K33/34; A61P31/14; A61P43/00
Domestic Patent References:
| JP2000510123A |
Foreign References:
| US10987329 | ||||
| US20210330622 | ||||
| WO2016163082A1 | ||||
| WO2014013664A1 | ||||
| WO2020218577A1 |
Other References:
Nature,2020年02月03日,Vol. 579,pp. 265-269
Free Radical Biology and Medicine,2020年10月19日,Vol. 161,pp. 263-271
Medical Hypotheses,2020年09月03日,Vol. 144, 110242,pp. 1-4
PLoS ONE,2008年,Vol. 3, issue 12, e4023,pp. 1-14
History of Changes for Study: NCT04542850,ClinicalTrials.gov archive [online], [retrieved on 2021.05.24],2020年09月06日,Retrieved from the Internet:
European Journal of Pharmacology,2018年,Vol. 833,pp. 25-33
Am J Physiol Cell Physiol,2015年,Vol. 308,pp. C665-C672
International Journal of Molecular Sciences,2015年,Vol. 16,pp. 25865-25880
Biochemical and Biophysical Research Communications,2021年01月29日,Vol. 545,pp. 203-207
Frontiers in Veterinary Science,2021年02月10日,Vol. 8, Article 647189,pp. 1-6
bioRxiv (INTERNET ARCHIVE WAYBACK MACHINE) [online], [retrieved on 2021.05.17],2020年11月05日,Retrieved from the Internet:
Bioorganic Chemistry,2021年01月05日,Vol. 107, 104619,pp. 1-11
Journal of Molecular Medicine,2020年06月29日,Vol. 98,pp. 1053-1054
Free Radical Biology and Medicine,2020年10月19日,Vol. 161,pp. 263-271
Medical Hypotheses,2020年09月03日,Vol. 144, 110242,pp. 1-4
PLoS ONE,2008年,Vol. 3, issue 12, e4023,pp. 1-14
History of Changes for Study: NCT04542850,ClinicalTrials.gov archive [online], [retrieved on 2021.05.24],2020年09月06日,Retrieved from the Internet:
European Journal of Pharmacology,2018年,Vol. 833,pp. 25-33
Am J Physiol Cell Physiol,2015年,Vol. 308,pp. C665-C672
International Journal of Molecular Sciences,2015年,Vol. 16,pp. 25865-25880
Biochemical and Biophysical Research Communications,2021年01月29日,Vol. 545,pp. 203-207
Frontiers in Veterinary Science,2021年02月10日,Vol. 8, Article 647189,pp. 1-6
bioRxiv (INTERNET ARCHIVE WAYBACK MACHINE) [online], [retrieved on 2021.05.17],2020年11月05日,Retrieved from the Internet:
Bioorganic Chemistry,2021年01月05日,Vol. 107, 104619,pp. 1-11
Journal of Molecular Medicine,2020年06月29日,Vol. 98,pp. 1053-1054
Attorney, Agent or Firm:
Makoto Ono
Yoshie Sakurada
Yosuke Kawasaki
Yasufumi Shiroyama
Yoshie Sakurada
Yosuke Kawasaki
Yasufumi Shiroyama